Silver Rock Financial LP Takes Position in Phoenix Biotech Acquisition Corp. (NASDAQ:PBAXU)

Silver Rock Financial LP purchased a new stake in shares of Phoenix Biotech Acquisition Corp. (NASDAQ:PBAXUGet Rating) during the fourth quarter, HoldingsChannel.com reports. The fund purchased 46,243 shares of the company’s stock, valued at approximately $463,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in PBAXU. Sage Mountain Advisors LLC purchased a new stake in shares of Phoenix Biotech Acquisition during the 4th quarter valued at about $653,000. Wealthspring Capital LLC purchased a new stake in shares of Phoenix Biotech Acquisition during the 4th quarter valued at about $2,653,000. Robinson Capital Management LLC bought a new position in shares of Phoenix Biotech Acquisition in the 4th quarter worth approximately $61,000. Condor Capital Management bought a new position in shares of Phoenix Biotech Acquisition in the 4th quarter worth approximately $64,000. Finally, Yakira Capital Management Inc. bought a new stake in Phoenix Biotech Acquisition during the 4th quarter worth approximately $1,009,000.

NASDAQ PBAXU remained flat at $$10.06 on Thursday. 51 shares of the company’s stock were exchanged, compared to its average volume of 4,652. Phoenix Biotech Acquisition Corp. has a 12 month low of $9.94 and a 12 month high of $11.21. The firm’s 50 day moving average price is $10.08 and its 200-day moving average price is $10.10.

About Phoenix Biotech Acquisition (Get Rating)

Phoenix Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It engages in identifying and acquiring a business that focuses on the healthcare or healthcare related industries in the United States and Europe.

See Also

Want to see what other hedge funds are holding PBAXU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phoenix Biotech Acquisition Corp. (NASDAQ:PBAXUGet Rating).

Institutional Ownership by Quarter for Phoenix Biotech Acquisition (NASDAQ:PBAXU)

Receive News & Ratings for Phoenix Biotech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phoenix Biotech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.